Ten-League International is a Singapore infrastructure-equipment supplier whose first year as a Nasdaq listing has been defined less by the operating print than by a bid-price fight, a reverse split, and a panel monitor that still runs into next spring. The fiscal year that ended in late 2025 produced a real earnings inflection on Changi Terminal Five, Mass Rapid Transit civil works, and a follow-on electrification order from PSA Singapore after the company commissioned the first battery charging and swap station outside China. The public equity still trades as if that operating year never happened. The investment debate is whether a profitable, cash-converting supplier is being priced as a distressed stub because the listing is fragile, or whether concentration and a working-capital structure that still leans on related-party payables justify the discount.
The income statement and the cash-flow statement finally lined up. Revenue rose by about 30 percent. Converted sales reached roughly $59 million. Net income nearly tripled. Dollar profit landed near $4 million. Operating cash far outran reported profit because the rental fleet is now mostly owned rather than subleased. Gross margin widened as equipment mix improved and rental utilization of owned iron replaced third-party hire. That is the constructive case in one paragraph. The offset sits on the balance sheet. Current liabilities still exceed current assets. Bank debt is almost entirely short-dated. Payables to related parties remain larger than year-end cash.
A mid-September quote near $6 implies a market value of about $17 million and a single-digit earnings multiple on last year's profit. Average volume is a few thousand shares. The float after the reverse split is thin enough that listing optics still dominate the tape. The next test is whether the first half of the current fiscal year, still unreported in the United States record, keeps the mix and the cash conversion, and whether the bid stays clear of another staff determination under the mandatory monitor.